KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Leases: 2013-2025

Historic Leases for Sarepta Therapeutics (SRPT) over the last 7 years, with Sep 2025 value amounting to $139.2 million.

  • Sarepta Therapeutics' Leases fell 1.23% to $139.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $139.2 million, marking a year-over-year decrease of 1.23%. This contributed to the annual value of $148.3 million for FY2024, which is 14.13% up from last year.
  • As of Q3 2025, Sarepta Therapeutics' Leases stood at $139.2 million, which was down 2.71% from $143.0 million recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Leases registered a high of $148.3 million during Q4 2024, and its lowest value of $43.0 million during Q3 2022.
  • Moreover, its 3-year median value for Leases was $134.7 million (2023), whereas its average is $129.9 million.
  • In the last 5 years, Sarepta Therapeutics' Leases slumped by 50.38% in 2021 and then soared by 210.11% in 2023.
  • Quarterly analysis of 5 years shows Sarepta Therapeutics' Leases stood at $45.5 million in 2021, then soared by 42.66% to $65.0 million in 2022, then soared by 100.07% to $130.0 million in 2023, then rose by 14.13% to $148.3 million in 2024, then declined by 1.23% to $139.2 million in 2025.
  • Its last three reported values are $139.2 million in Q3 2025, $143.0 million for Q2 2025, and $147.1 million during Q1 2025.